Drug Type ASO |
Synonyms XCUR 17, XCUR17 |
Target |
Action antagonists |
Mechanism IL-17RA antagonists(Interleukin-17 receptor A antagonists), RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 1 | Germany | - | |
Congenital Ichthyosiform Erythroderma | Preclinical | United States | - | 13 Jul 2019 |
Alopecia | Preclinical | United States | 09 Jul 2019 |